Immunovant Inc.

IMVT | NASDAQ

Price Alert Chart Builder DCF Calculator

$37.18

+$0.23 (+0.62%)

At close: Sep 21, 2026, 4:00 PM ET

$37.08

-$0.10 (-0.27%)

Pre-market: Sep 22, 2026, 5:14 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 30, 2026	FY 2025 Mar 30, 2025	FY 2024 Mar 30, 2024	FY 2023 Mar 30, 2023	FY 2022 Mar 30, 2022	FY 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	409K	n/a	n/a	n/a	n/a	n/a
Gross Profit	-409K	n/a	n/a	n/a	n/a	n/a
Operating Income	-532.9M	-438.15M	-270.21M	-208.28M	-156.03M	-108.12M
Interest Income	25.33M	24.73M	24.95M	7.58M	n/a	n/a
Pretax Income	-505.39M	-412.95M	-258.77M	-210.95M	-156.81M	-107.79M
Net Income	-505.61M	-413.84M	-259.34M	-210.96M	-156.73M	-107.43M
Selling & General & Admin	76.24M	77.24M	57.28M	48.02M	54.23M	39.51M
Research & Development	456.66M	360.92M	212.93M	160.26M	101.81M	68.6M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	532.9M	438.15M	270.21M	208.28M	156.03M	108.12M
Interest Expense	n/a	n/a	n/a	12.48M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	532.9M	438.15M	270.21M	208.28M	156.03M	108.12M
Income Tax Expense	215K	891K	567K	9K	-84K	-358K
Shares Outstanding (Basic)	182.42M	151.57M	138.1M	123.08M	109.68M	87.76M
Shares Outstanding (Diluted)	182.42M	151.57M	138.1M	123.08M	109.68M	87.76M
EPS (Basic)	-2.77	-2.73	-1.88	-1.71	-1.43	-1.22
EPS (Diluted)	-2.77	-2.73	-1.88	-1.71	-1.43	-1.22
EBITDA	-504.98M	-412.57M	-258.54M	-198.28M	-156.69M	-108.05M
EBIT	-505.39M	-412.95M	-258.77M	-198.47M	-156.81M	-108.12M
Depreciation & Amortization	409K	377K	231K	193K	126K	65K